A carregar...
The Osteocyte as the New Discovery of Therapeutic Options in Rare Bone Diseases
Osteocytes are the most abundant (~95%) cells in bone with the longest half-life (~25 years) in humans. In the past osteocytes have been regarded as vestigial cells in bone, since they are buried inside the tough bone matrix. However, during the last 30 years it has become clear that osteocytes are...
Na minha lista:
| Publicado no: | Front Endocrinol (Lausanne) |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7360678/ https://ncbi.nlm.nih.gov/pubmed/32733380 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2020.00405 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|